The challenges in diagnosis and treatment of multiple myeloma in Latin America: a multinational survey and proposal for improvement
DOI:
https://doi.org/10.46765/2675-374X.2025v7n1e346Keywords:
Health services accessibility, Hematologic neoplasms, Surveys and questionnaires, Developing countries, Diagnostic services, Healthcare disparitiesAbstract
Multiple myeloma (MM) is a malignant hematologic disease marked by the abnormal growth of plasma cells, resulting in serious complications such as bone fractures, hypercalcemia, renal dysfunction, and anemia. It represents the second most frequent hematologic malignancy and is usually diagnosed at an advanced stage in Latin America. A multinational survey included 16 experts from 11 Latin American countries to share their experiences in myeloma healthcare, discuss existing gaps, and propose solutions. The public healthcare system struggles with slow diagnosis and treatment access, particularly in rural areas. The private system faces challenges related to insurance coverage and costs. A significant gap exists between the need for diagnostic tests and their availability. Access to new cancer treatments is hindered by inadequate public policies, high drug costs, and inconsistent approval processes. A comprehensive approach for improving MM management in Latin America is crucial, emphasizing training, access, stakeholder engagement, data enhancement, and financial resources.
References
1. Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J
Hematol. 2022;97(8):1086-107. https://doi.org/10.1002/ajh.26590 DOI: https://doi.org/10.1002/ajh.26590
2. Sergentanis TN, Zagouri F, Tsilimidos G, Tsagianni A, Tseliou M, Dimopoulos MA, et al. Risk factors for
multiple myeloma: a systematic review of meta-analyses. Clin Lymphoma Myeloma Leuk. 2015;15(10): 563-77.e1-3. https://doi.org/10.1016/j.clml.2015.06.003 DOI: https://doi.org/10.1016/j.clml.2015.06.003
3. Guedes A, Becker RG, Teixeira LEM. Multiple myeloma (Part 1): update on epidemiology, diagnostic criteria, systemic treatment and prognosis. Rev Bras Ortop (Sao Paulo). 2023;58(3):361-7. https://doi.org/10.1055/s-0043-1770149 DOI: https://doi.org/10.1055/s-0043-1770149
4. World Health Organization. Cancer today. Lyon: International Agency for Research on Cancer; [cited 2024 Oct 8]. Available from: https://gco.iarc.who.int/today/en/dataviz/tables?mode=cancer&
group_populations=1&multiple_populations=1&types=1
5. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660 DOI: https://doi.org/10.3322/caac.21660
6. de Moraes Hungria VT, Martínez-Baños DM, Peñafiel CR, Miguel CE, Vela-Ojeda J, Remaggi G, et al. Multiple myeloma treatment patterns and clinical outcomes in the Latin America Haemato-Oncology (HOLA) observational study, 2008-2016. Br J Haematol. 2020;188:383-93. https://doi.org/10.1111/bjh.16124 DOI: https://doi.org/10.1111/bjh.16124
7. Curado MP, Oliveira MM, Silva DRM, Souza DLB. Epidemiology of multiple myeloma in 17 Latin American countries: an update. Cancer Med. 2018;7(5):2101-8. https://doi.org/10.1002/cam4.1347 DOI: https://doi.org/10.1002/cam4.1347
8. Peña C, Riva E, Schutz N, Tarín-Arzaga L, Martínez-Cordero H, Bove V, et al. Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study. Leuk Lymphoma. 2020;61(13):3112-9. https://doi.org/10.1080/10428194.2020.1804558 DOI: https://doi.org/10.1080/10428194.2020.1804558
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Camila Peña, Breno Gusmão , Eloisa Riva, Alana von Glasenapp, Dorotea Fantl, Rodrigo Meneces, Aline Ramírez, David Gomez Almaguer, Julio Dámaso Fernández-Aguila, Manolo Antônio Granja, Esmedaly Romero, Jule Vasquez, Humberto Martinez-Cordero , Ariel Corzo, Rafael Cunha, Fernanda Lemos Moura, Maria Victoria Mateos
This work is licensed under a Creative Commons Attribution 4.0 International License.
